Quoc Tran
Interventional Pain Medicine · Cookeville, TNNPI 1457764342
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Spinal Simplicity, LLC at 31.7% of the total. Reporting peaked in 2024 at $2,944 and has fallen 59.0% since, to $1,207 in 2025.
Across 222 payments — averaging $40.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$3K
- Boston Scientific$3K
- Nevro Corp.$1K
- Medtronic$660
- Curonix LLC$475
- Painteq LLC$418
- plus $1K from 15 others
What the payments were for
- Travel & lodging$3,86744%
- Food & beverage$4,60352%
- Education$4185%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 11 | $2,815 |
| Boston Scientific | 100 | $2,505 |
| Nevro Corp. | 46 | $1,010 |
| Medtronic(2 entities) | 12 | $660 |
| Curonix LLC | 4 | $475 |
| Painteq LLC | 2 | $418 |
| Collegium Pharmaceutical, Inc. | 20 | $220 |
| Stryker | 1 | $170 |
| Relievant Medsystems, Inc. | 1 | $124 |
| MML US, Inc. | 2 | $86 |
| AbbVie(2 entities) | 3 | $74 |
| Saluda Medical Americas, Inc. | 3 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $66 |
| Scilex Pharmaceuticals Inc. | 3 | $42 |
| Pacira Pharmaceuticals Incorporated | 1 | $36 |
| Stimwave Technologies Incorporated | 2 | $30 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Globus Medical | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Vertex | 1 | $17 |
| SPR Therapeutics, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$2,610
- Superion Indirect Decompression System$631
- LIBERTY SI$453
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$381
- PAINTEQ$378
- OSTEOCOOL RF ABLATION$291
- Intracept$247
- SPECTRA WAVEWRITER$231
- mild Device Kit$170
- Omnia$157
- KYPHON Balloon Kyphoplasty$128
- Senza Spinal Cord Stimulation System$126
How this compares
$8,888 in reported general payments places this provider in the 70th percentile of 41 interventional pain medicine providers in Tennessee.
See all interventional pain medicine providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,360 | $36,823 |
| Xtampza ErOxycodone Myristate | 133 | $35,640 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,014 | $23,834 |
| LinzessLinaclotide | 28 | $16,883 |
| MovantikNaloxegol Oxalate | 27 | $13,379 |
| Gabapentin | 1,046 | $12,194 |
| Pregabalin | 413 | $8,108 |
| Buprenorphine | 37 | $8,024 |
| Lidocaine | 66 | $7,210 |
| Oxycodone Hcl | 258 | $4,135 |
| Tizanidine Hcl | 292 | $2,923 |
| Morphine Sulfate ErMorphine Sulfate | 153 | $2,554 |
| Naloxone Hcl | 31 | $1,957 |
| Diclofenac Sodium | 54 | $1,857 |
| Lubiprostone | 11 | $1,396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $220 | $35,640133 claims |
| AbbVieLinzess | $74 | $16,88328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 41 interventional pain medicine providers in Tennessee.
Other interventional pain medicine in Cookeville
- William NewtonWinchester$225K
- Ryan BearerWinchester$35K
- Michael WilkinsonJohnson City$35K
- Jacob MillsMountain Home$24K
- Matthew KangasMemphis$22K
- Matthew RupertFranklin$17K
- Adolfo CuadraKnoxville$15K
- Cameron ShawverJohnson City$15K
- Christine LeslieMorristown$12K
- Madhu YelameliColumbia$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.